Menzies School of Health Research
menzies.edu.auLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
45
Active
7
Phase 3
12
Total enrollment
20,282
Pipeline matrix
Showing 10 of 10 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Patients with G6PD enzyme activities between 30 and <70% of the AMM will be treated with schizontocidal treatment plus high dose primaquine 1mg/kg/day for 7 days | — | — | — | — | — | 1 | |
| Patients with G6PD enzyme activities <30% of the AMM will be treated with schizontocidal treatment plus 8 weekly primaquine (0.75mg/kg dose). | — | — | — | — | — | 1 | |
| Tafenoquine plus DHA-Piperaquine | — | — | — | — | — | 1 | |
| Tafenoquine plus Artesunate-pyronaridine | — | — | — | — | — | 1 | |
| Nirsevimab | — | — | — | — | — | 1 | |
| Tafenoquine | — | — | — | — | — | 2 | |
| Sulfadoxine pyrimethamine | — | — | — | — | — | 1 | |
| High dose ultra short Primaquine | — | — | — | — | — | 1 | |
| Primaquine | — | — | — | 8 | |||
| Dihydroartemisinin-Piperaquine | — | — | — | — | 2 |
Next readouts
- 2025-03-31
- 2027-03-01
- 2027-12-01
- 2028-06
- 2028-06-30
- 2030-07-31
Top conditions
- Malaria12
- Vivax Malaria9
- Otitis Media4
- Falciparum Malaria3
- Malaria, Vivax3
- G6PD Deficiency2
- Malaria, Falciparum2
- Uncomplicated Plasmodium Knowlesi Malaria1
Frequently asked questions about Menzies School of Health Research
- How many clinical trials does Menzies School of Health Research have on ClinicalTrials.gov?
- Menzies School of Health Research is listed as the lead sponsor on 45 clinical trials in ClinicalTrials.gov, 7 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Menzies School of Health Research's trials are in Phase 3?
- 12 of Menzies School of Health Research's trials are in Phase 3, spread across 10 active drug programs.
- What therapeutic areas does Menzies School of Health Research focus on?
- Menzies School of Health Research's most-studied conditions on ClinicalTrials.gov are Malaria, Vivax Malaria, Otitis Media, Falciparum Malaria, Malaria, Vivax.
- When are Menzies School of Health Research's next clinical trial readouts?
- Menzies School of Health Research has 6 upcoming primary-completion readouts tracked here; the soonest is “Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy”, expected around 2025-03-31.